Marksans Pharma Limited (BOM:524404)

Paycor HCM Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 29, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	101,898	100,815	68,836	31,903	18,627	20,445
Market Cap Growth	46.46%	46.46%	115.77%	71.27%	-8.89%	259.35%
Enterprise Value	98,282	96,315	63,549	29,746	16,052	19,467
Last Close Price	224.60	222.35	151.24	69.95	44.98	49.16
PE Ratio	26.77	26.49	21.94	11.98	9.97	8.57
PS Ratio	3.89	3.84	3.16	1.72	1.25	1.49
PB Ratio	4.09	4.05	3.30	1.81	1.52	2.26
P/TBV Ratio	4.33	4.28	3.51	1.95	1.67	2.50
P/FCF Ratio	301.97	298.76	319.14	17.36	35.20	15.47
P/OCF Ratio	49.31	48.78	29.88	13.44	18.77	11.45
EV/Sales Ratio	3.75	3.67	2.92	1.61	1.08	1.42
EV/EBITDA Ratio	18.61	19.21	14.65	9.29	6.68	5.81
EV/EBIT Ratio	22.08	21.63	16.54	10.34	7.50	6.30
EV/FCF Ratio	291.25	285.42	294.63	16.19	30.33	14.73
Debt / Equity Ratio	0.13	0.13	0.12	0.07	0.09	0.04
Debt / EBITDA Ratio	0.61	0.61	0.53	0.36	0.43	0.12
Debt / FCF Ratio	9.54	9.54	11.32	0.67	2.09	0.30
Asset Turnover	0.89	0.89	0.89	0.97	1.04	1.29
Inventory Turnover	1.64	1.64	1.95	2.07	1.76	1.87
Quick Ratio	2.64	2.64	2.99	3.34	2.09	1.62
Current Ratio	4.62	4.62	4.78	4.91	3.37	3.02
Return on Equity (ROE)	16.73%	16.73%	16.35%	17.76%	17.55%	30.69%
Return on Assets (ROA)	9.40%	9.40%	9.86%	9.39%	9.33%	18.13%
Return on Capital (ROIC)	10.82%	10.82%	11.39%	11.16%	11.75%	23.74%
Return on Capital Employed (ROCE)	16.10%	16.10%	16.80%	15.60%	16.70%	33.30%
Earnings Yield	3.73%	3.77%	4.56%	8.35%	10.03%	11.67%
FCF Yield	0.33%	0.34%	0.31%	5.76%	2.84%	6.46%
Dividend Yield	0.34%	0.36%	0.40%	0.71%	0.56%	0.51%
Payout Ratio	7.14%	7.14%	7.22%	3.82%	5.67%	1.72%
Buyback Yield / Dilution	-	-	-9.09%	-1.49%	-	0.00%
Total Shareholder Return	0.34%	0.36%	-8.69%	-0.77%	0.56%	0.51%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.